BML, Inc. to absorb subsidiary BLH in merger

BML, Inc. (TSE:4694) announced today that its Board of Directors has approved an absorption-type merger with its wholly-owned subsidiary, BML Life Science Holdings, Inc. (BLH). The merger, scheduled to take effect on September 1, 2025, aims to enhance the overall management efficiency of the BML Group. As BLH is already a 100% owned entity, no new shares will be issued, and there will be no changes to BML, Inc.’s capital structure, business description, head office location, representative, or fiscal year-end as a result of the merger. BLH, a holding company overseeing BML Food Science Solutions, Inc. and Allegro, Inc., will be dissolved. For BML, the merger is a simplified process under Article 796, Paragraph 2 of the Companies Act, while for BLH, it is a short-form merger under Article 784, Paragraph 1. While BML, Inc. reported consolidated net sales of JPY143,191 million and a profit of JPY6,509 million for the fiscal year ended March 31, 2025, BML expects the merger to have minimal impact on its consolidated business results.